• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

西苯唑啉对一名肥厚型梗阻性心肌病患儿双心室压力梯度的影响。

Effect of cibenzoline on biventricular pressure gradients in a pediatric patient with hypertrophic obstructive cardiomyopathy.

作者信息

Ishikawa Takamichi, Iwashima Satoru, Ohzeki Takehiko

机构信息

Department of Pediatrics, Hamamatsu University School of Medicine, Higashi-ku, Hamamatsu, Japan.

出版信息

Pediatr Cardiol. 2010 Jul;31(5):707-10. doi: 10.1007/s00246-010-9651-7. Epub 2010 Feb 7.

DOI:10.1007/s00246-010-9651-7
PMID:20140606
Abstract

This report presents the case of an 8-year-old male with biventricular hypertrophic obstructive cardiomyopathy who achieved a successful reduction of the pressure gradients by treatment with cibenzoline. Ultrasound echocardiography showed marked intraventricular septal hypertrophy and left midventricular and right ventricular outflow obstructions. A cardiac catheterization revealed left midventricular and right outflow obstructions associated with pressure gradients of 100 and 35 mmHg, respectively. An intravenous injection of 28 mg (1.4 mg/kg) cibenzoline immediately improved the biventricular pressure gradients. Therefore, oral cibenzoline treatment was initiated, the dose was increased to 150 mg/day, and both pressure gradients remained low, without any complications at the time of discharge, 4 months later.

摘要

本报告介绍了一名8岁男性双心室肥厚型梗阻性心肌病患者,通过西苯唑啉治疗成功降低了压力阶差。超声心动图显示明显的室间隔肥厚以及左心室中部和右心室流出道梗阻。心导管检查显示左心室中部和右心室流出道梗阻,压力阶差分别为100 mmHg和35 mmHg。静脉注射28 mg(1.4 mg/kg)西苯唑啉后,双心室压力阶差立即得到改善。因此,开始口服西苯唑啉治疗,剂量增加至150 mg/天,4个月后出院时,两个压力阶差均保持较低水平,且无任何并发症。

相似文献

1
Effect of cibenzoline on biventricular pressure gradients in a pediatric patient with hypertrophic obstructive cardiomyopathy.西苯唑啉对一名肥厚型梗阻性心肌病患儿双心室压力梯度的影响。
Pediatr Cardiol. 2010 Jul;31(5):707-10. doi: 10.1007/s00246-010-9651-7. Epub 2010 Feb 7.
2
Attenuation of biventricular pressure gradients by cibenzo-line in an 18-year-old patient with hypertrophic obstructive cardiomyopathy.西苯唑啉对一名18岁肥厚型梗阻性心肌病患者双心室压力梯度的衰减作用
Circ J. 2002 Dec;66(12):1173-5. doi: 10.1253/circj.66.1173.
3
Effect of cibenzoline, a class ia antiarrhythmic agent, on left ventricular diastolic function in hypertrophic cardiomyopathy.Ⅰa类抗心律失常药西苯唑啉对肥厚型心肌病左心室舒张功能的影响。
Cardiovasc Drugs Ther. 2001 Sep;15(5):459-65. doi: 10.1023/a:1013366211927.
4
Antiarrhythmic drug cibenzoline attenuates left ventricular pressure gradient and improves transmitral Doppler flow pattern in patients with hypertrophic obstructive cardiomyopathy caused by midventricular obstruction.抗心律失常药物西苯唑啉可减轻由心室中部梗阻引起的肥厚性梗阻性心肌病患者的左心室压力梯度,并改善二尖瓣多普勒血流模式。
Circ J. 2005 Aug;69(8):940-5. doi: 10.1253/circj.69.940.
5
Cibenzoline improves coronary flow velocity reserve in patients with hypertrophic obstructive cardiomyopathy.西苯唑啉可改善肥厚性梗阻性心肌病患者的冠状动脉血流速度储备。
Heart Vessels. 2006 Nov;21(6):350-5. doi: 10.1007/s00380-006-0917-1. Epub 2006 Nov 27.
6
Antiarrhythmic agent cibenzoline attenuates latent obstruction in the left ventricular outflow tract of hypertrophic cardiomyopathy.抗心律失常药物西苯唑啉可减轻肥厚型心肌病左心室流出道的潜在梗阻。
Int J Cardiol. 2011 May 5;148(3):359-61. doi: 10.1016/j.ijcard.2010.09.001. Epub 2010 Oct 2.
7
An early systolic sound associated with midventricular obstruction in a patient with hypertrophic cardiomyopathy.肥厚型心肌病患者中与心室中部梗阻相关的收缩期早期声音。
Jpn Circ J. 1998 May;62(5):385-8. doi: 10.1253/jcj.62.385.
8
[Beneficial effect of cibenzoline in a patient with hypertrophic obstructive cardiomyopathy complicated with idiopathic interstitial pneumonia].[西苯唑啉对一名肥厚性梗阻性心肌病合并特发性间质性肺炎患者的有益作用]
Nihon Ronen Igakkai Zasshi. 2003 Jan;40(1):62-4. doi: 10.3143/geriatrics.40.62.
9
Effect of cibenzoline on regional left ventricular function in hypertrophic obstructive cardiomyopathy.昔苯唑啉对肥厚性梗阻性心肌病局部左心室功能的影响。
Clin Cardiol. 2000 Sep;23(9):689-96. doi: 10.1002/clc.4960230911.
10
Pharmacogenetic interactions between Angiotensin-converting enzyme insertion/deletion polymorphism and response to cibenzoline in patients with hypertrophic obstructive cardiomyopathy.血管紧张素转换酶插入/缺失多态性与西布曲明在肥厚型梗阻性心肌病患者中的反应的药物遗传学相互作用。
J Cardiovasc Pharmacol. 2010 May;55(5):506-10. doi: 10.1097/FJC.0b013e3181d8bc4b.

引用本文的文献

1
Mid-term outcomes of biventricular obstruction and left ventricular outflow tract obstruction after surgery correction in child and adolescent patients with hypertrophic cardiomyopathy.肥厚型心肌病儿童及青少年患者手术矫正后双心室梗阻和左心室流出道梗阻的中期结果
PLoS One. 2018 Feb 6;13(2):e0192218. doi: 10.1371/journal.pone.0192218. eCollection 2018.

本文引用的文献

1
Clinical features and outcomes of childhood hypertrophic cardiomyopathy: results from a national population-based study.儿童肥厚型心肌病的临床特征与转归:一项基于全国人群研究的结果
Circulation. 2005 Aug 30;112(9):1332-8. doi: 10.1161/CIRCULATIONAHA.104.530303. Epub 2005 Aug 22.
2
A novel mutation in the PTPN11 gene in a patient with Noonan syndrome and rapidly progressive hypertrophic cardiomyopathy.一名患有努南综合征和快速进展性肥厚型心肌病患者的PTPN11基因新突变。
Eur J Pediatr. 2005 Aug;164(8):497-500. doi: 10.1007/s00431-005-1679-y. Epub 2005 May 12.
3
Beneficial effect of cibenzoline on left ventricular pressure gradient with sigmoid septum.
昔苯唑啉对伴有S形室间隔的左心室压力梯度的有益作用。
Circ J. 2004 Oct;68(10):968-71. doi: 10.1253/circj.68.968.
4
Echocardiographic assessment of right ventricular obstruction in hypertrophic cardiomyopathy.肥厚型心肌病右心室梗阻的超声心动图评估
Circ J. 2003 Oct;67(10):855-60. doi: 10.1253/circj.67.855.
5
Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy.肥厚型心肌病中左心室流出道梗阻对临床结局的影响。
N Engl J Med. 2003 Jan 23;348(4):295-303. doi: 10.1056/NEJMoa021332.
6
Attenuation of biventricular pressure gradients by cibenzo-line in an 18-year-old patient with hypertrophic obstructive cardiomyopathy.西苯唑啉对一名18岁肥厚型梗阻性心肌病患者双心室压力梯度的衰减作用
Circ J. 2002 Dec;66(12):1173-5. doi: 10.1253/circj.66.1173.
7
Antiarrhythmic drug, cibenzoline, can directly improve the left ventricular diastolic function in patients with hypertrophic cardiomyopathy.抗心律失常药物西苯唑啉可直接改善肥厚型心肌病患者的左心室舒张功能。
Jpn Circ J. 2001 Jun;65(6):531-8. doi: 10.1253/jcj.65.531.
8
Clinical course of hypertrophic cardiomyopathy in a regional United States cohort.美国某地区队列中肥厚型心肌病的临床病程
JAMA. 1999 Feb 17;281(7):650-5. doi: 10.1001/jama.281.7.650.
9
Class Ia antiarrhythmic drug cibenzoline: a new approach to the medical treatment of hypertrophic obstructive cardiomyopathy.I类抗心律失常药物西苯唑啉:肥厚性梗阻性心肌病药物治疗的新方法。
Circulation. 1997 Sep 2;96(5):1520-4. doi: 10.1161/01.cir.96.5.1520.
10
Hypertrophic obstructive cardiomyopathy in pediatric patients: results of surgical treatment.小儿肥厚型梗阻性心肌病:外科治疗结果
J Thorac Cardiovasc Surg. 1996 Dec;112(6):1589-97; discussion 1597-9. doi: 10.1016/S0022-5223(96)70018-1.